What Researchers Did
The researchers measured hearing before and after a course of hyperbaric oxygen treatment (HBOT) in 59 people with sudden hearing loss of unknown cause who were treated with HBOT alone.
What They Found
In 59 patients with idiopathic sudden sensorineural hearing loss treated with HBOT only (90 minutes at 203 kPa daily for 20 days), hearing thresholds were significantly lower after treatment than before, with a median recovery of 22.5 dB. The interquartile range was 12.5 to 33.7 dB, and the change was significant across all patients (p less than 0.001). Thresholds were also significantly lower at 500, 1,000, 2,000 and 4,000 Hz (p less than 0.001). The largest change was at 1,000 Hz, a median of 32 dB, but this was not significantly different from the other frequencies (p = 0.10).
What This Means for Canadian Patients
For people with sudden hearing loss of unknown cause, this abstract reports lower hearing thresholds after a 20-day course of HBOT given as the primary treatment. The authors describe HBOT as a legitimate choice for primary treatment, especially if it is readily accessible and if there are contraindications for corticosteroid therapy. The abstract reports no comparison group, so it cannot show how HBOT compares with other treatments.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a single group of 59 patients who all received HBOT with no comparison group reported, so it cannot show that the hearing improvement was caused by the treatment.